Financials
- Market Capitalization 208.49 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.34
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3580 | CHRS Coherus Oncology, Inc. - Common Stock | 1.36 USD | +0.74% | -2.16% | -4.23% | -15.53% | 210.12 M USD | ||
| 3581 | DTIL Precision BioSciences, Inc. - Common Stock | 7.61 USD | -0.39% | -11.72% | +6.43% | +57.56% | 210.05 M USD | ||
| 3589 | ANTX AN2 Therapeutics, Inc. - Common Stock | 5.50 USD | -0.90% | -2.65% | +2.04% | +391.07% | 207.55 M USD | ||
| 3591 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.10 USD | -0.73% | -7.24% | +7.61% | -43.60% | 207.28 M USD |